FDA Adverse Event Malfunction Summary report: N

I-STAT CTNI CARTRIDGE

MDR report key: 1132663 · Received August 13, 2008

Report

Report Number
2245578-2008-00062
Event Type
Malfunction
Date Received
August 13, 2008
Date of Event
August 7, 2008
Report Date
August 13, 2008
Manufacturer
ABBOTT POINT OF CARE INC.
Product Code
MMI
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

ABBOTT HAS COMPLETED ITS TESTING OF THE HEPARIN LOTS FOR PRODUCTS MEETING THE CRITERIA FOR A 5-DAY MDR AS DESCRIBED IN THE FDA'S NOTICE DATED APRIL 8, 2008 [TO MANUFACTURERS AND INITIAL DISTRIBUTORS OF MEDICAL DEVICES THAT MAY CONTAIN HEPARIN OR ARE HEPARIN-COATED]. THE HEPARIN LOTS IDENTIFIED IN THE APOC MANUFACTURING PROCESS HAVE PASSED THE NUCLEAR MAGNETIC RESONANCE (NMR) AND CAPILLARY ELECTROPHORESIS (CE) TESTS. BECTON DICKINSON (BD) TUBE TESTING WILL COMMENCE PENDING THE APPROVAL, BY FDA, OF THE PROTOCOL.

Description of Event or Problem · 1

THIS PRODUCT MEETS THE CRITERIA FOR A 5-DAY MDR AS DESCRIBED IN THE FDA'S NOTICE DATED APRIL 8, 2008 [TO MANUFACTURERS AND INITIAL DISTRIBUTORS OF MEDICAL DEVICES THAT MAY CONTAIN HEPARIN OR ARE HEPARIN-COATED], AND ABBOTT IS SUBMITTING THIS 5-DAY MDR. OUR INVESTIGATION INTO THIS EVENT IS ONGOING AND A SUPPLEMENTAL MDR WILL BE SUBMITTED AT THE CONCLUSION OF OUR INVESTIGATION. IN 2008, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER WHO REPORTED USING AN I-STAT CARDIAC TROPONIN I CARTRIDGE ON WHOLE BLOOD YIELDED A RESULT OF 0.42 NG/ML AND 1.60 NG/ML. SECOND DRAW, TESTED USING AN I-STAT CARDIAC TROPONIN I CARTRIDGE YIELDED A RESULT OF 0.76 NG/ML. UNSURE IF SAME SAMPLES, CUSTOMER STATED "ALL TROPONIN TESTING ON THE PLASMA SAMPLES WERE 0.00."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 I-STAT CTNI CARTRIDGE IVD MMI ABBOTT POINT OF CARE INC. NA T08114

Patients

Seq Age Sex Outcome Treatment
1 63 YR